UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1561) 1561
pyrazinamide - therapeutic use (1294) 1294
antitubercular agents - therapeutic use (1086) 1086
science & technology (1001) 1001
isoniazid - therapeutic use (960) 960
rifampin - therapeutic use (943) 943
life sciences & biomedicine (939) 939
female (847) 847
male (835) 835
adult (728) 728
tuberculosis, pulmonary - drug therapy (656) 656
tuberculosis (639) 639
drug therapy, combination (574) 574
ethambutol - therapeutic use (543) 543
middle aged (504) 504
pyrazinamide (469) 469
infectious diseases (447) 447
biological and medical sciences (428) 428
medical sciences (424) 424
tuberculosis - drug therapy (388) 388
adolescent (329) 329
pyrazinamide - administration & dosage (311) 311
mycobacterium tuberculosis - drug effects (299) 299
treatment outcome (288) 288
aged (276) 276
rifampin - administration & dosage (275) 275
streptomycin - therapeutic use (261) 261
isoniazid - administration & dosage (259) 259
antitubercular agents - administration & dosage (253) 253
isoniazid (248) 248
pharmacology & pharmacy (241) 241
bacterial diseases (234) 234
microbiology (233) 233
pharmacology. drug treatments (231) 231
abridged index medicus (216) 216
rifampin (213) 213
animals (211) 211
human bacterial diseases (202) 202
time factors (201) 201
mycobacterium tuberculosis - isolation & purification (198) 198
antitubercular agents - adverse effects (197) 197
child (189) 189
respiratory system (184) 184
tuberculosis and atypical mycobacterial infections (180) 180
antibiotics. antiinfectious agents. antiparasitic agents (176) 176
pyrazinamide - adverse effects (173) 173
mycobacterium tuberculosis (164) 164
pyrazinamide - pharmacology (157) 157
antitubercular agents - pharmacology (150) 150
drug resistance (150) 150
drug therapy (145) 145
tuberculosis, pulmonary - microbiology (144) 144
tuberculosis, multidrug-resistant - drug therapy (143) 143
antibiotics, antitubercular - therapeutic use (141) 141
ethambutol (140) 140
general & internal medicine (138) 138
drug administration schedule (135) 135
drug resistance, microbial (134) 134
ethambutol - administration & dosage (132) 132
young adult (131) 131
ethionamide - therapeutic use (130) 130
microbial sensitivity tests (127) 127
immunology (125) 125
rifampin - adverse effects (125) 125
sputum - microbiology (124) 124
follow-up studies (122) 122
antibacterial agents (121) 121
drugs (116) 116
drug combinations (114) 114
isoniazid - adverse effects (114) 114
retrospective studies (112) 112
child, preschool (110) 110
medicine, general & internal (110) 110
antitubercular agents (108) 108
mice (108) 108
recurrence (100) 100
cycloserine - therapeutic use (99) 99
tuberculosis, pulmonary - diagnosis (95) 95
infant (94) 94
tuberculosis, pulmonary - complications (94) 94
mycobacterium tuberculosis - genetics (90) 90
risk factors (89) 89
antitubercular agents - pharmacokinetics (87) 87
pyrazinamide - pharmacokinetics (85) 85
prospective studies (84) 84
medicine (82) 82
isoniazid - pharmacology (81) 81
research article (81) 81
patients (79) 79
chemotherapy (78) 78
health aspects (76) 76
streptomycin - administration & dosage (75) 75
aged, 80 and over (74) 74
aids/hiv (74) 74
radiography (73) 73
rifampicin (72) 72
clinical trials as topic (71) 71
care and treatment (70) 70
analysis (69) 69
research (68) 68
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1590) 1590
French (82) 82
Spanish (63) 63
German (53) 53
Russian (46) 46
Portuguese (21) 21
Japanese (19) 19
Italian (17) 17
Polish (13) 13
Chinese (11) 11
Turkish (7) 7
Dutch (4) 4
Hebrew (2) 2
Hungarian (2) 2
Romanian (2) 2
Swedish (2) 2
Danish (1) 1
Korean (1) 1
Slovak (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Lancet infectious diseases, ISSN 1473-3099, 2016, Volume 17, Issue 1, pp. 39 - 49
Journal Article
The Journal of infectious diseases, ISSN 0022-1899, 1/2013, Volume 207, Issue 1, pp. 9 - 17
Epidemics | Ferries | BACTERIA | Tuberculosis | Disease transmission | Mycobacterium tuberculosis | HIV | Hospital admissions | Data transmission | Multidrug resistant tuberculosis | Infection control | Genotyping | Drug resistance | Transmission | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Fundamental and applied biological sciences. Psychology | Biological and medical sciences | Infectious diseases | Medical sciences | Prevalence | Humans | Male | Cross Infection - complications | Cross Infection - transmission | Adult | Extensively Drug-Resistant Tuberculosis - microbiology | Female | Isoniazid - therapeutic use | Rifampin - therapeutic use | Retrospective Studies | Drug Therapy, Combination | Ethambutol - therapeutic use | Antitubercular Agents - therapeutic use | Cross Infection - epidemiology | Extensively Drug-Resistant Tuberculosis - complications | Mycobacterium tuberculosis - classification | HIV Infections - virology | South Africa - epidemiology | Genotype | Sequence Analysis, DNA | Mycobacterium tuberculosis - isolation & purification | Pyrazinamide - therapeutic use | Extensively Drug-Resistant Tuberculosis - epidemiology | Hospitals, Rural | Polymorphism, Restriction Fragment Length | Extensively Drug-Resistant Tuberculosis - transmission | Cross Infection - microbiology | HIV Infections - complications | Mutation | Cluster Analysis | Mycobacterium tuberculosis - genetics | Extensively drug-resistant tuberculosis | Distribution | Reports | Cross infection | Research | Nosocomial infections | Risk factors | Index Medicus | Abridged Index Medicus | Major and Brief Reports | transmission | drug resistance | tuberculosis | genotyping
Journal Article
Journal Article
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 02/2013, Volume 57, Issue 2, pp. 1019 - 1024
Pharmacology & Pharmacy | Life Sciences & Biomedicine | Microbiology | Science & Technology | Immunopathology | Tuberculosis and atypical mycobacterial infections | Viral diseases | Biological and medical sciences | Medical sciences | Immunodeficiencies | Infectious diseases | Bacterial diseases | Human bacterial diseases | Pharmacology. Drug treatments | Viral diseases of the lymphoid tissue and the blood. Aids | Human viral diseases | Immunodeficiencies. Immunoglobulinopathies | Antibiotics. Antiinfectious agents. Antiparasitic agents | Oxidoreductases, N-Demethylating - genetics | Reverse Transcriptase Inhibitors - blood | Humans | Middle Aged | Aryl Hydrocarbon Hydroxylases - genetics | Tuberculosis - complications | Male | Tenofovir | Young Adult | Drug Interactions | Adenine - therapeutic use | Tuberculosis - drug therapy | Lamivudine - therapeutic use | Adult | Anti-HIV Agents - therapeutic use | Benzoxazines - blood | Female | Isoniazid - therapeutic use | Rifampin - therapeutic use | Anti-HIV Agents - blood | Reverse Transcriptase Inhibitors - therapeutic use | Ethambutol - therapeutic use | Antitubercular Agents - therapeutic use | HIV Infections - blood | Pharmacogenetics | Adenine - analogs & derivatives | Organophosphonates - therapeutic use | Genotype | Pyrazinamide - therapeutic use | Benzoxazines - therapeutic use | Adolescent | HIV Infections - complications | HIV Infections - drug therapy | Polymorphism, Single Nucleotide | Cytochrome P-450 CYP2B6 | Index Medicus | Body weight | Clinical Therapeutics
Journal Article